Curious to see your top suppliers emissions?
Book a demo for a pilot project
Biopharma, officially known as Biopharma Limited, is a leading player in the biopharmaceutical industry, headquartered in Bangladesh (BD). Established in 2006, the company has rapidly expanded its operations across South Asia, focusing on the development and manufacturing of innovative biopharmaceutical products.
Specialising in monoclonal antibodies, biosimilars, and recombinant proteins, Biopharma distinguishes itself through its commitment to quality and affordability, catering to both local and international markets. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position.
With a strong emphasis on research and development, Biopharma continues to contribute to the healthcare landscape, making strides in the treatment of various diseases while maintaining a reputation for excellence in the biopharma sector.
10
DitchCarbon score
-22 vs industry average
Biopharma’s score of 10 is lower than 8% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Biopharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Medical Device Manufacturing has below-average carbon intensity
Industry performance
0.308
20182025
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Reported emissions
No reported emissions data is available for Biopharma yet.
Biopharma's reported carbon emissions
Biopharma, headquartered in BD, currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established specific reduction targets or climate pledges. Without emissions data or defined commitments, it is challenging to assess Biopharma's climate impact or initiatives. The absence of reported figures suggests that the company may still be in the early stages of developing its sustainability strategy or may rely on broader industry standards for climate action.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Biopharma’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Biopharma yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Biopharma yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more